Circadian Rhythm Sleep Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Afri

Circadian Rhythm Sleep Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The global Circadian Rhythm Sleep Treatment Market is poised for significant growth from 2024 to 2031. Starting at US$ 740 million in 2024, the market is projected to expand to US$ 990 million by 2031.

Growth Factors:

The global Circadian Rhythm Sleep Treatment Market is witnessing significant growth due to the rising prevalence of sleep disorders, including Delayed Sleep Phase Syndrome, Advanced Sleep Phase Syndrome, Non–24-h sleep-wake syndrome. This increased need for proper sleep treatment is driving market expansion. Additionally, the market is propelled by product advancements in therapy devices and the adoption of drugs for circadian rhythm sleep treatment.

Furthermore, a disrupted sleep pattern poses an increased risk of fatal accidents, with estimates suggesting a potential doubling of global deaths in car accidents and a notable portion attributed to exhaustion or drowsiness. Similarly, workplace accidents are projected to rise due to disrupted sleep. This elevated risk of fatal accidents contributes to an increased demand for circadian rhythm sleep treatment, further propelling market growth.

Restraints

Limited awareness about the critical issues related to circadian rhythm sleep disorders in underdeveloped nations could hinder the expansion of the circadian rhythm sleep treatment market. Additionally, negligence towards potential drug side effects and insufficient attention to sleep problems may impede the market's growth.

Competitive Analysis

The Circadian Rhythm Sleep Treatment industry is characterized by intense competition and significant consolidation, primarily driven by major players. Mergers and acquisitions are prominent strategies as the industry experiences growth. Key market players are strategically opting for these initiatives to expand their product portfolios and increase market share.

One notable player, Natus Medical Incorporated in the USA, has introduced the Embla N7000 system designed for overnight PSG (Polysomnography) between 10 p.m. and 6 a.m. The system is supervised by experienced sleep physicians following the guidelines outlined in the AASM manual 2.5.

In addition to inorganic expansion through mergers and acquisitions, companies are also exploring organic growth strategies. Continuous innovation remains vital for the circadian rhythm sleep treatment market, and this trend is expected to persist throughout the forecast period (2024-2031).

Key players in the Circadian Rhythm Sleep Treatment Market including:
• Natus Medical Incorporated
• Compumedics Ltd. -
• Teva Pharmaceutical Industries Ltd
• Takeda Pharmaceutical Company
• Koninklijke Philips N.V
• Mylan N.V
• Fitbit, Inc
• Garmin Ltd
• Lucimed S.A.
• RedMed Inc.
• Compass Health Brands (Carex Health)
• Beurer GmbH
• Samarit Medical AG
• Lanaform N.V.

Circadian Rhythm Sleep Treatment Market Categorization

Circadian Rhythm Sleep Treatment Market by Disorder
• Delayed Sleep Phase Syndrome
• Advanced Sleep Phase Syndrome
• Non–24-h sleep-wake syndrome
• Irregular Sleep-Wake Disorder
• Shift Work Disorder
• Jet Lag

Circadian Rhythm Sleep Treatment Market by Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa (MEA)

Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.